Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation

ABBOTT PARK, Ill., March 19, 2018 — Abbott today announced that the Ministry of Health Labour and Welfare (MHLW) in Japan granted national reimbursement for the company's MitraClip therapy to treat people with mitral regurgitation, a serious, progressive heart disease in which the mitral valve does not close properly, allowing blood to flow backward into the heart.

Philips collaborates with two Boston-based academic medical centers to advance digital pathology adoption across the U.S.

Philips IntelliSite Pathology Solution. Photo courtesy of Royal Philips. 

Royal Philips, a global leader in health technology, today announced Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH), both members of the Partners HealthCare network, will implement the Philips IntelliSite Pathology Solution to enable research and support clinical diagnosis.